Tackling HPV detection and the global cervical cancer prevalence problem
Speaking with experts in the field, including LGC Biosearch Technologies, a company that specializes in supporting the molecular diagnostics industry, and some of its customers working to develop PCR-based HPV assays, SelectScience explores the front line of the response to the global cervical cancer prevalence problem.